Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

» Details

Guru Trades

IWB Guru Trades in

IWB Guru Trades in

IWB Guru Trades in

Q4 2016

IWB Guru Trades in Q4 2016

Chris Davis 1,848 sh (New)
Wallace Weitz 1,550 sh (New)
» More

Ratios

vs
industry
vs
history
PE Ratio 20.78
IWB's PE Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IWB: 20.78 )
Ranked among companies with meaningful PE Ratio only.
IWB' s PE Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 21.12
Current: 20.78
0
21.12
PE Ratio without NRI 20.78
IWB's PE Ratio without NRI is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IWB: 20.78 )
Ranked among companies with meaningful PE Ratio without NRI only.
IWB' s PE Ratio without NRI Range Over the Past 10 Years
Min: 0  Med: 0 Max: 21.12
Current: 20.78
0
21.12
PB Ratio 2.80
IWB's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IWB: 2.80 )
Ranked among companies with meaningful PB Ratio only.
IWB' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.85
Current: 2.8
0
2.85

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.84
IWB's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IWB: 1.84 )
Ranked among companies with meaningful Dividend Yield % only.
IWB' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.02
Current: 1.84
0
2.02
5-Year Yield-on-Cost % 1.84
IWB's 5-Year Yield-on-Cost % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IWB: 1.84 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
IWB' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.02
Current: 1.84
0
2.02

More Statistics

Short Percentage of Float0.00%
52-Week Range $107.15 - 132.15
Shares Outstanding (Mil)99,999,999.99
» More Articles for IWB

Headlines

Articles On GuruFocus.com
Ken Heebner's CGM Mutual Fund 4th Quarter Commentary Feb 28 2017 
Valeant Pharmaceuticals Is a Potential Sell Feb 28 2017 
Buffett Stocks in Focus: General Motors Feb 28 2017 
Sony Is a Buy Feb 28 2017 
A Quality Dividend Aristocrat for Long-term Income and Growth Feb 28 2017 
American Assets Trust CEO Invests in Company Feb 28 2017 
New Features Added to Financials Page Feb 27 2017 
Utility Dividend Growth: Southern Company vs. Consolidated Edison Feb 27 2017 
Searching For Value Feb 27 2017 
The Best Way to Beat the S&P 500 Feb 27 2017 

More From Other Websites
These Factors Could Improve AMAT’s Profitability in 2017 Feb 15 2017
Should You Bother With a 'Tax-Managed' Fund? Feb 15 2017
[$$] Value Investors, Relax Feb 04 2017
Can AbbVie’s Anti-Tau Therapeutics Help Late-Stage Alzheimer’s Patients? Dec 01 2016
Clinical Trial Data Shows Efficacy of Elagolix to Treat Uterine Fibroids Nov 30 2016
AbbVie Hopes to Commercialize Next-Generation HCV Regimen by 2017 Nov 30 2016
Understanding Medtronic’s Weak CVG Segment Performance in Fiscal 2Q17 Nov 28 2016
AnacorAcquisition Added Crisaborole to Pfizer’s Portfolio Nov 17 2016
What’s National Oilwell Varco’s Historical Valuation? Nov 15 2016
Is National Oilwell Varco’s Net Debt Falling? Nov 14 2016
National Oilwell Varco’s Growth Prospects in 4Q16 and 2017 Nov 14 2016
How Do Amgen’s Valuation Multiples Compare to Its Peers’? Nov 04 2016
Bill Gross: Monetary Policy on Steady but Slow Path Nov 04 2016
Next Bear Market Could Catch Many Off Guard Oct 01 2016
Last 3 Spikes In The Ted Spread: Did Stocks Tank? Sep 26 2016
Three Charts To Assist With Fed Week Sep 19 2016
Value & Large Cap: 2 ETFs Trading with Outsized Volume Sep 13 2016
Is Your Portfolio’s Performance Satisfactory? Aug 30 2016
Top Small-Cap Funds Let You Be Cheap Without Compromising On Quality Aug 19 2016
Disappointing Active Strategies Help Put Focus on Passive ETFs Aug 12 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK